Brazil's Bolsonaro stable but test results worsen, medical note says
Brazil’s former President Jair Bolsonaro looks on from his home as Sao Paulo’s Governor Tarcisio de Freitas (not pictured) leaves after a visit in Brasilia, Brazil September 29, 2025. REUTERS/Diego Herculano
BRASILIA, March 14 (Reuters) - Brazil's imprisoned former President Jair Bolsonaro remained stable in an intensive care unit on Saturday after being diagnosed with bronchopneumonia, but tests showed worsening kidney function and higher inflammatory markers, according to a medical note.
The DF Star hospital in Brasilia said there is no forecast for the former president's discharge. Bolsonaro, 70, continues to receive treatment including antibiotics, intravenous hydration, respiratory and motor physiotherapy, and preventive measures against venous thrombosis, it added.
He was hospitalized on Friday after an episode of bronchoaspiration that led to bronchopneumonia, a lung infection that spreads from the airways into the lungs and can cause breathing difficulties.
Bolsonaro is serving a 27-year sentence for plotting a coup after losing the 2022 presidential election to current President Luiz Inacio Lula da Silva.
Bolsonaro's family and lawyers have sought to have the former president transferred to house arrest since he was jailed last year. Justice Alexandre de Moraes, who oversees the case, has denied previous petitions, with a panel at the court upholding his decision.
(Reporting by Marcela AyresEditing by Rod Nickel)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US to finalize sharply lower vehicle fuel economy standards
- Nor'easter leaves over 100,000 customers without power in US Northeast, over 400 flights canceled
- Analysis-Venezuela president returns from US visit with no deals, no firm election date
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share